- Q1 2024 Agenus Inc Earnings Call TranscriptMay 07, 2024$12.01 (-7.26%)Earnings
- Q4 2023 Agenus Inc Earnings Call and Corporate Update TranscriptMar 14, 2024$11.99 (-8.94%)Earnings
- Q3 2023 Agenus Inc Earnings Call and To Provide Corporate Update TranscriptNov 07, 2023$16.4 (+4.94%)Earnings
- Agenus Inc To Host Endpoints Webinar TranscriptOct 18, 2023
- Agenus Inc at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Q1 2023 Agenus Inc Earnings Call TranscriptMay 09, 2023$30 (-5.66%)Earnings
- Agenus Inc at H.C. Wainwright BioConnect Investor Conference TranscriptMay 02, 2023
- Q4 2022 Agenus Inc Earnings Call TranscriptMar 14, 2023$35.13 (+4.68%)Earnings
- Agenus Inc at B Riley Securities Oncology Conference (Virtual) TranscriptJan 18, 2023
- Agenus Inc to Host “The Road Taken” R&D Event TranscriptNov 12, 2022
- Q3 2022 Agenus Inc Earnings Call TranscriptNov 08, 2022$43.77 (-6.69%)Earnings
- Q2 2022 Agenus Inc Earnings Call TranscriptAug 09, 2022$50.24 (-1.92%)Earnings
- Agenus Inc To Review Late-Breaking Botensilimab and Balstilimab Data Presented at ESMO World GI Congress TranscriptJun 29, 2022
- Q1 2022 Agenus Inc Earnings Call TranscriptMay 10, 2022$32.58 (+9.21%)Earnings
- Q4 2021 Agenus Inc Earnings Call TranscriptMar 01, 2022$50.83 (-4.07%)Earnings
- Q3 2021 Agenus Inc Earnings Call TranscriptNov 09, 2021$87.34 (+6.46%)Earnings
- Agenus Inc Business Update Call TranscriptOct 22, 2021
- Q2 2021 Agenus Inc Earnings Call TranscriptAug 09, 2021$105.98 (-4.09%)Earnings
- Agenus Inc at Raymond James Human Health Innovation Conference (Virtual) TranscriptJun 22, 2021
- Agenus Inc Discuss the Global Licensing Agreement Between Agenus and Bristol Myers Squibb - Corporate Call TranscriptMay 18, 2021
- Q1 2021 Agenus Inc Earnings Call TranscriptMay 06, 2021$55.35 (-4.24%)Earnings
- Q4 2020 Agenus Inc Earnings Call TranscriptMar 15, 2021$66.73 (+2.72%)Earnings
- Agenus Inc. - Special Call TranscriptFeb 11, 2021
- Agenus Inc at Jefferies Virtual London Healthcare Conference TranscriptNov 17, 2020
- Q3 2020 Agenus Inc Earnings Call TranscriptOct 29, 2020$73.01 (+0.81%)Earnings
- Agenus Inc. - Special Call TranscriptSep 21, 2020
- Q2 2020 Agenus Inc Earnings Call TranscriptAug 06, 2020$64.96 (-0.90%)Earnings
- Agenus Inc Annual Shareholders Meeting TranscriptJun 16, 2020
- Agenus Inc. - Special Call TranscriptJun 02, 2020
- Q1 2020 Agenus Inc Earnings Call TranscriptMay 07, 2020$49.85 (-3.79%)Earnings
- Q4 2019 Agenus Inc Earnings Call TranscriptMar 12, 2020$51.22 (-4.04%)Earnings
- Agenus Inc Corporate Analyst Meeting TranscriptFeb 20, 2020
- Agenus Inc. - Special Call TranscriptNov 15, 2019
- Q3 2019 Agenus Inc Earnings Call TranscriptNov 04, 2019$60.25 (+7.72%)Earnings
- Q2 2019 Agenus Inc Earnings Call TranscriptAug 08, 2019$51.03 (+18.72%)Earnings
- Agenus Inc Annual Shareholders Meeting TranscriptJun 19, 2019
- Q1 2019 Agenus Inc Earnings Call TranscriptMay 09, 2019$56.52 (+8.27%)Earnings
- Q4 2018 Agenus Inc Earnings Call TranscriptMar 14, 2019$58.68 (+1.01%)Earnings
- Agenus Inc. - Special Call TranscriptFeb 19, 2019
Q4 2023 Agenus Inc Earnings Call and Corporate Update Transcript
Good morning. My name is Audra, and I will be your conference operator today. At this time, I would like to welcome everyone to the Agenus Inc., fourth-quarter and full-year 2023 results conference call. Today's conference is being recorded. (Operator Instructions) At this time I would like to turn the conference over to Zach Armen, Head of Investor Relations. Please go ahead.
Thank you, Audra, and thank you all for joining us today.
Today's call is being webcast and will be available on our website for replay. I'd like to remind you that this call will include forward-looking statements, including statements regarding our clinical development, regulatory and commercial plans and timelines, as well as time lines for data release and partnership opportunities among other updates. These statements are subject to risks and uncertainties. I refer you to our SEC filings available on our website for more details on these risks.
Joining me today are Dr. Garo Armen, Chairman and Chief Executive Officer, Dr. Steven O'Day,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)